Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials

Vaccine

Volumn 25, Issue 32, 2007, Pages 6140-6145

  Makoschey, B ^a   Sonnemans, D ^a   Bielsa, J Muñoz ^a   Franken, P ^b   Mars, M ^b   Santos, L ^c   Alvarez M ^d  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b GD ANIMAL HEALTH   (Netherlands)

^c Intervet Laboratories SA   (Spain)

^d UNIVERSITY OF LEÓN   (Spain)

Author keywords

BVDV; Cattle; Vaccine

Indexed keywords

BOVILIS; INACTIVATED VIRUS VACCINE; NONSTRUCTURAL PROTEIN 3; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOASSAY; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; PEPTIDE HYDROLASES; RNA HELICASES; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 34447537807     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.110     Document Type: Article

References (20)

1. Moennig V., Houe H., and Lindberg A. BVD control in Europe: current status and perspectives. Anim Health Res Rev 6 (2005) 63-74
2. Lindberg A.L., and Alenius S. Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populations. Vet Microbiol 64 (1999) 197-222
3. van Oirschot J.T., Gielkens A.L., Moormann R.J., and Berns A.J. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet Microbiol 23 (1990) 85-101
4. Kaashoek M.J., Moerman A., Madic J., Rijsewijk F.A., Quak J., Gielkens A.L., et al. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12 (1994) 439-444
5. Hulst M.M., Westra D.F., Wensvoort G., and Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 67 (1993) 5435-5442
6. Bruschke C.J.M., Moormann R.J.M., van Oirschot J.T., and van Rijn P.A. A subunit vaccine based on glycoprotein E2 of bovine viurs diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 15 (1997) 1940-1945
7. Liang R., van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., et al. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Vaccine 23 (2005) 5252-5262
8. Bruderer U., Swam H., Haas B., Visser N., Brocchi E., Grazioli S., et al. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. Vet Microbiol 101 (2004) 187-197
9. Graham D.A., German A., Mawhinney K.A., and Goodall E.A. Antibody responses of naive cattle to two inactivated bovine viral diarrhoea virus vaccines, measured by indirect and blocking ELISA's and virus neutralisation. Vet Rec 152 (2003) 795-800
10. Corapi W.V., Donis R.O., and Dubovi E.J. Monoclonal antibody analyses of cytopathic and noncytopathic viruses from fatal bovine viral diarrhea virus infections. J Virol 62 (1988) 2823-2827
11. Makoschey B., Janssen M.G.J., Vrijenhoek M.P., Korsten J.H.M., and Van der Marel P. An inactivated Bovine virus diarrhoea virus (BVDV) type1 vaccine affords clinical protection against BVDV type2. Vaccine 19 (2001) 3261-3268
12. Arias P., Valdazo B., Fernández M., and Álvarez M. Comparison of four commercially available ELISA tests with the virus neutralisation test before and after the application of a BVDV inactivated vaccine in cattle. Proceedings of the Fifth Pestivirus Symposium European Society for Veterinary Virology. Cambridge, UK (2002) p. 99
13. Edwards S., Sands J.J., and Harkness J.W. The application of monoclonal antibody panels to characterize pestivirus isolates from ruminants in Great Britain. Arch Virol 102 (1988) 197-206
14. van der Poel W.H.M., Kramps J.A., Quak J., Brand A., and van Oirschot J.T. Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine. Vet Rec 137 (1995) 347-348
15. Waage S., Krogsrud J., and Nyberg O. Proceedings of the 18th World Buiatrics Congress. Bolognia. The Norwegian programme for eradication of BVD/mucosal disease (1994) 773-776
16. Bitsch V., Hansen K.E., and Ronsholt L. Experiences from the Danish programme for eradication of bovine virus diarrhoea (BVD) 1994-1998 with special reference to legislation and causes of infection. Vet Microbiol 77 (2000) 137-143
17. Lindberg A. Epidemiology and eradication of BVDV infections. Veterinary University Uppsala, Sweden, PhD Thesis, 2002.
18. Mars M.H., and Van Maanen C. Diagnostic assays applied in BVDV control in The Netherlands. Prev Vet Med 72 (2005) 43-48
19. Paton D.J., Ibata G., Edwards S., and Wensvoort G. An ELISA detecting antibody to conserved pestivirus epitopes. J Virol Meth 31 (1991) 315-324
20. Arias P, Santos LF, Álvarez M. Evaluation of the antibody response induced in naive cattle by an inactivated bovine viral diarrhoea virus vaccine. In Proceedings of the 23rd World Buiatrics Congress 2004:13.